Navigation Links
Jazz Pharmaceuticals Appoints Head of Research and Development
Date:9/27/2011

PALO ALTO, Calif., Sept. 27, 2011 /PRNewswire/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company has appointed Jeffrey Tobias, MD, as Senior Vice President of Research & Development and Chief Medical Officer, effective October 17.

"Jeff has a unique combination of drug development skills and broad medical knowledge, combined with a passion for the commercial side of the business," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.  "His breadth of experience, business acumen, strong intellect and focus on patients will serve us well as we build a targeted pipeline of important new medical treatments that will complement our growing commercial products."

Dr. Tobias has twenty years of experience in the biopharmaceutical industry across all phases of drug development, including regulatory filings in the U.S. and Europe.  He has broad experience with a variety of therapeutic products spanning numerous clinical areas, including pain and neurological disorders.  Most recently, he served as Executive Vice President of Research & Development at NeurogesX, where he has also been Chief Medical Officer since 2005.  He was previously Managing Director of an independent biopharmaceutical consulting firm from 1996 to 2006, where he supported clients in all aspects of clinical development, technology assessment and strategic planning.  Prior to that, he served in various roles in drug discovery and clinical development at ALZA, Chiron and XOMA. 

In addition to his expertise in the creation, evaluation, and development of novel products utilizing proprietary drug-delivery technologies, Dr. Tobias has ten years of experience in clinical and academic medicine in the areas of internal medicine, pulmonary and critical care medicine.  He received board-certification in both Internal Medicine and Pulmonary Medicine and completed training in Critical Care Medicine at the University of California, Los Angeles. He received his bachelor's degree and medical degree with honors from the University of Illinois.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.  For further information see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... LONDON , Feb. 9, 2016 Hearing ... amount of sound energy transmitted to the inner ear. ... and hearing bands. These devices are recommended for users ... eight hours. Earplugs refer to HPD that are inserted ... attenuation earplugs are designed to provide more natural sound ...
(Date:2/9/2016)... -- Increasingly, health care professionals are enhancing patient care and ... With the Vios Monitoring System from Vios Medical, health ... problems before they become serious by continuously tracking and ... the United States . --> ... --> The Vios Monitoring System connects patient-worn sensors, ...
(Date:2/9/2016)... -- The new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: ... reveals that the North America continued to ... 2014 that translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... The global anti-bacterial market is inclined towards North America ...
Breaking Medicine Technology:
(Date:2/9/2016)... Cambridge, MA (PRWEB) , ... February 09, 2016 ... ... Institute (WCRI) compares the workers’ compensation fee schedule rates and Medicare rates for ... medical services covered in the report, Evaluation of the 2015 Fee Schedule ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 Paul ... appointment after they noticed their furnace not producing any heat. Shortly after entering the ... cracked heat exchanger was leaking dangerous levels of carbon monoxide into the home, at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... guide will ensure lab personnel have a basic understanding of the techniques they ... protocols. Enhanced understanding will help them reduce waste and rework to create a ...
(Date:2/9/2016)... ... 2016 , ... i2i Systems, an early innovator and developer of population health ... latest KLAS report, Population Health Management 2015: How Far Can Your Vendor Take You? ... management (PHM). The latest KLAS Report, leveraging over 200 user interviews, shines a ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... BASF Human Nutrition into the Food & Beverage and Dietary ... BASF’s channel partner throughout Canada and USA geographies east of the Rocky Mountains ...
Breaking Medicine News(10 mins):